Connelly Robert 4
4 · Elicio Therapeutics, Inc. · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Connelly Robert
DirectorCEO, President and Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-03+121,600→ 121,600 totalExercise: $8.92Exp: 2035-02-03→ Common Stock (121,600 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to 25% of the options on the first anniversary of the grant date (February 3, 2026), with the remaining options vesting in equal monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.